Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERISCOPE trial of selective digestive decontamination after esophagectomy
NL-OMON60445Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of colistin and tobramycin in esophageal cancer (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Postoperative pneumonia within 30 days. Started Oct 2024; status: recruiting.
02
Drugs
colistintobramycin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NL-OMON60445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60445.